Insmed launches BRINSUPRI tablets in Japan
Insmed launched BRINSUPRI 25 mg tablets (brensocatib hydrate) for non-cystic fibrosis bronchiectasis in Japan.
Insmed launched BRINSUPRI 25 mg tablets (brensocatib hydrate) for non-cystic fibrosis bronchiectasis in Japan.